Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
暂无分享,去创建一个
Ralph Weissleder | Umar Mahmood | Lynda Chin | Cameron Brennan | Gerald C. Chu | Kuang-Hung Cheng | Douglas Hanahan | L. Chin | D. Hanahan | C. Brennan | B. Feng | R. DePinho | R. Weissleder | A. Hezel | G. Chu | N. Bardeesy | U. Mahmood | A. Aguirre | M. Redston | Nabeel Bardeesy | Ronald A Depinho | Mark S Redston | L. Lopez | Gerald C Chu | Bin Feng | Andrew J Aguirre | Kuang-Hung Cheng | Aram F Hezel | Lyle V Lopez | Bin Feng
[1] N. Sharpless,et al. INK4a/ARF: a multifunctional tumor suppressor locus. , 2005, Mutation research.
[2] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[3] R. Hruban,et al. Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion , 2005, Modern Pathology.
[4] M. Blasco. Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging , 2005, The EMBO journal.
[5] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[6] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[7] R. Weinberg,et al. Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.
[8] L. Chin,et al. High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Veltman,et al. Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. , 2004, Cancer research.
[10] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[11] David Hawke,et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. , 2003, Molecular cell.
[12] J. Cameron,et al. Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray , 2003, Modern Pathology.
[13] S. Lowe,et al. Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.
[14] Mei-Ling Kuo,et al. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. , 2003, Molecular cell.
[15] Scott E Kern,et al. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. , 2002, The American journal of pathology.
[16] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[17] R. DePinho,et al. Connecting chromosomes, crisis, and cancer. , 2002, Science.
[18] D. Melton,et al. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.
[19] M. Loda,et al. Obligate Roles for p16Ink4a and p19Arf-p53 in the Suppression of Murine Pancreatic Neoplasia , 2002, Molecular and Cellular Biology.
[20] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[21] D. Carrasco,et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.
[22] L. Chin,et al. Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas , 2001, Molecular and Cellular Biology.
[23] J. Rüschoff,et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. , 2000, The American journal of pathology.
[24] R. Hruban,et al. Genetic progression in the pancreatic ducts. , 2000, The American journal of pathology.
[25] A. Berns,et al. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. , 2000, Genes & development.
[26] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Serrano,et al. p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.
[28] A. Foulis. Book Review: AFIP Atlas of Tumot Patholgoy (3rd series, Fascicle 20). Tumours of the Pancreas. Enrico Solcia, Carlo Capella and Gunter Kloppel, Armed Forces Institute of Pathology, Washington, DC , 1998 .
[29] N. Lemoine,et al. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki‐ras mutations provides evidence of a ductal origin , 1998, The Journal of pathology.
[30] Ken Chen,et al. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.
[31] Yue Xiong,et al. ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.
[32] P. Gumerlock,et al. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study. , 1998, Archives of pathology & laboratory medicine.
[33] G. Klöppel,et al. Tumors of the Pancreas , 1997 .
[34] B. Amati,et al. Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins , 1997, The EMBO journal.
[35] C. Moskaluk,et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.
[36] S. Goodman,et al. Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.
[37] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[38] P. Goodfellow,et al. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. , 1995, The New England journal of medicine.
[39] A M Goldstein,et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. , 1995, The New England journal of medicine.
[40] S. Stryker,et al. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. , 1994, The American journal of pathology.
[41] J. Cameron,et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. , 1994, The American journal of pathology.